It looks like we’ll be testing some of the support levels I talked about last night. Let’s see if buyers step in at those levels.
On Today’s Calendar:
- nothing
More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic
Potential swing trades:
See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
Gapping down on weak earnings/guidance/same store sales: INPH -26.8%, OBCI -8.7%, RIMM -7.0%, NICH -6.5%, MW -5.6%, BEBE -5.1%, MTG -5.0, BBBY -3.5%… Other news: CECE -7.0% (announces follow-on offering), DNDN -6.7% (Brean Murray notes they are confident the FDA will not approve Provenge), CEGE -4.9% (continued profit taking)
Gapping Up
Gapping up on strong earnings/guidance/same store sales: APOG +4.9%, PIR +4.7%, CDWC +3.3%, ANF +3.0%… Other news: NFI +15.3% (announces commitment for an additional $100 mln in liquidity; co to explore strategic alternatives), AMAG +14.2% (announces positive results from two additional Phase III studies of Ferumoxytol), AFFY +10.3% (announces results from Phase 2 clinical trial of Hematide), COLY +10.1% (licenses VaxImmune to Merck for use in vaccine programs), IPS +5.4% (Reuters reports Russia’s Evraz is in talks to buy IPSCO), MEDI +4.3% (to explore strategic alternatives), VG +3.7% (CEO steps down, co issues Q1 guidance), LFC +3.9%.
Disclaimer & How I use this list
